---
title: "CD55 Is Induced by PGE2–EP4–Gi–p38 MAPK Signaling in Colorectal Cancer Cells"
id: "pubmed-42551717"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42551717"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42551717/"
doi: "10.1016/j.gene.2026.150339"
published_at: "2026-11-20T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# CD55 Is Induced by PGE2–EP4–Gi–p38 MAPK Signaling in Colorectal Cancer Cells
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42551717
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42551717/)
- **DOI:** [10.1016/j.gene.2026.150339](https://doi.org/10.1016%2Fj.gene.2026.150339)
- **Published At:** 2026-11-20T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The study identified **CD55** (decay-accelerating factor) as a downstream target of prostaglandin E2 (**PGE2**) signaling via the E-type prostanoid **EP4** receptor in colorectal cancer (CRC) models. - Transcriptomic profiling of PGE2-treated HCA-7 human colon cancer cells was integrated with cancer genomic databases to predict CD55 as an EP4-regulated gene. - Inhibitor experiments in HCA-7 cells indicated that CD55 induction after PGE2 exposure required the **EP4** receptor and a **Gi protein** coupling; protein kinase A signaling was not required. - A toxicogenomic database search implicated **p38 MAPK** as the predominant effector linking EP4/Gi signaling to upregulation of CD55. - Single-cell RNA-seq re-analysis of human CRC tissues showed increased CD55 expression and enrichment of p38 MAPK–related gene sets in epithelial cells that express EP4, implying this signaling axis may occur in a subset of tumor epithelial cells in clinical specimens. - The study delineates a signaling axis: PGE2 → EP4 receptor → Gi protein → p38 MAPK → CD55 induction in HCA-7 cells and in EP4-positive epithelial tumor cells. - The source did not report specific experimental dosing, time-course parameters, or detailed sample sizes in the abstract; full-method details require consultation of the full text.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42551717/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42551717%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42551717/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42551717/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42551717/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42551717/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42551717/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42551717%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42551717%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42551717/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42551717/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42551717/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42551717/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Elsevier Science full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif) Elsevier Science ](https://linkinghub.elsevier.com/retrieve/pii/S0378-1119\(26\)00349-5 "See full text options at Elsevier Science") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42551717/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42551717/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42551717/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42551717/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42551717/#conflict-of-interest) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42551717/#similar) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42551717/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42551717/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42551717/#related-links) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42551717/#linkout) Title & authors Abstract Conflict of interest statement Similar articles MeSH terms Substances Related information LinkOut - more resources Gene Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gene%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Gene%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) . 2026 Nov 20:1011:150339. doi: 10.1016/j.gene.2026.150339. Epub 2026 Aug 4. # Identification of CD55 as a downstream factor of EP4 receptor signaling in colorectal cancer cells [Keijo Fukushima](https://pubmed.ncbi.nlm.nih.gov/?term=Fukushima+K&cauthor_id=42551717)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#full-view-affiliation-1 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: keijo.fukushima@tokushima-u.ac.jp."), [Isamu Konishi](https://pubmed.ncbi.nlm.nih.gov/?term=Konishi+I&cauthor_id=42551717)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#full-view-affiliation-2 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: cham136136@ymail.ne.jp."), [Ayaka Hamaguchi](https://pubmed.ncbi.nlm.nih.gov/?term=Hamaguchi+A&cauthor_id=42551717)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#full-view-affiliation-3 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: c402441006@tokushima-u.ac.jp."), [John W Regan](https://pubmed.ncbi.nlm.nih.gov/?term=Regan+JW&cauthor_id=42551717)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#full-view-affiliation-4 "Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States. Electronic address: jwregan@arizona.edu."), [Hiromichi Fujino](https://pubmed.ncbi.nlm.nih.gov/?term=Fujino+H&cauthor_id=42551717)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#full-view-affiliation-5 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: hfujino@tokushima-u.ac.jp.") Affiliations Expand ### Affiliations * 1 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: keijo.fukushima@tokushima-u.ac.jp. * 2 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: cham136136@ymail.ne.jp. * 3 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: c402441006@tokushima-u.ac.jp. * 4 Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States. Electronic address: jwregan@arizona.edu. * 5 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: hfujino@tokushima-u.ac.jp. * PMID: **42551717** * DOI: [ 10.1016/j.gene.2026.150339 ](https://doi.org/10.1016/j.gene.2026.150339) Item in Clipboard # Identification of CD55 as a downstream factor of EP4 receptor signaling in colorectal cancer cells Keijo Fukushima et al. Gene. 2026. Show details Display options Display options Format Abstract PubMed PMID Gene Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gene%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Gene%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) . 2026 Nov 20:1011:150339. doi: 10.1016/j.gene.2026.150339. Epub 2026 Aug 4. ### Authors [Keijo Fukushima](https://pubmed.ncbi.nlm.nih.gov/?term=Fukushima+K&cauthor_id=42551717)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#short-view-affiliation-1 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: keijo.fukushima@tokushima-u.ac.jp."), [Isamu Konishi](https://pubmed.ncbi.nlm.nih.gov/?term=Konishi+I&cauthor_id=42551717)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#short-view-affiliation-2 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: cham136136@ymail.ne.jp."), [Ayaka Hamaguchi](https://pubmed.ncbi.nlm.nih.gov/?term=Hamaguchi+A&cauthor_id=42551717)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#short-view-affiliation-3 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: c402441006@tokushima-u.ac.jp."), [John W Regan](https://pubmed.ncbi.nlm.nih.gov/?term=Regan+JW&cauthor_id=42551717)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#short-view-affiliation-4 "Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States. Electronic address: jwregan@arizona.edu."), [Hiromichi Fujino](https://pubmed.ncbi.nlm.nih.gov/?term=Fujino+H&cauthor_id=42551717)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42551717/#short-view-affiliation-5 "Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: hfujino@tokushima-u.ac.jp.") ### Affiliations * 1 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: keijo.fukushima@tokushima-u.ac.jp. * 2 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: cham136136@ymail.ne.jp. * 3 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: c402441006@tokushima-u.ac.jp. * 4 Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States. Electronic address: jwregan@arizona.edu. * 5 Department of Pharmacology for Life Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8505, Japan. Electronic address: hfujino@tokushima-u.ac.jp. * PMID: **42551717** * DOI: [ 10.1016/j.gene.2026.150339 ](https://doi.org/10.1016/j.gene.2026.150339) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Prostaglandin E2 (PGE2) signaling through the E-type prostanoid 4 (EP4) receptor has been implicated in the pathophysiology of colorectal cancer (CRC). We herein identified decay-accelerating factor, also known as CD55, as a novel CRC-associated downstream factor of the EP4 receptor. The integration of transcriptomic profiling of PGE2-stimulated HCA-7 human colon cancer cells with analyses of cancer genomic databases predicted CD55 as a potential EP4 receptor-regulated target. Inhibitor-based experiments showed the induction of CD55 after a PGE2 stimulation required the EP4 receptor and Gi protein in HCA-7 cells, whereas protein kinase A signaling was dispensable. In combination with a toxicogenomic database analysis, p38 mitogen-activated protein kinase (MAPK) was identified as the predominant effector connecting the EP4 receptor to CD55 upregulation. A single-cell RNA-seq re-analysis of human CRC tissues revealed CD55 upregulation and p38 MAPK-related gene set enrichment in epithelial cells expressing the EP4 receptor, suggesting that this induction mechanism may operate in a subset of epithelial cells in clinical specimens. Collectively, these results delineate a PGE2/EP4 receptor/Gi protein/p38 MAPK signaling axis that induces CD55 expression in HCA-7 cells and epithelial tumor cells, provide new mechanistic clues for understanding the regulation of complement regulatory molecule CD55 expression by prostaglandin signaling. **Keywords:** CD55; Colorectal cancer; EP4 prostanoid receptor; Genomic data science; Transcriptome analysis. Copyright © 2026 Elsevier B.V. All rights reserved. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ## Similar articles * [ Induction of cyclooxygenase-2 expression by prostaglandin E2 stimulation of the prostanoid EP4 receptor via coupling to Gαi and transactivation of the epidermal growth factor receptor in HCA-7 human colon cancer cells. ](https://pubmed.ncbi.nlm.nih.gov/23973650/) Yoshida K, Fujino H, Otake S, Seira N, Regan JW, Murayama T.Yoshida K, et al.Eur J Pharmacol. 2013 Oct 15;718(1-3):408-17. doi: 10.1016/j.ejphar.2013.08.002. Epub 2013 Aug 22.Eur J Pharmacol. 2013.PMID: 23973650 * [ Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway. ](https://pubmed.ncbi.nlm.nih.gov/25109834/) Xia S, Ma J, Bai X, Zhang H, Cheng S, Zhang M, Zhang L, Du M, Wang Y, Li H, Rong R, Shi F, Yang Q, Leng J.Xia S, et al.Oncol Rep. 2014 Oct;32(4):1521-30. doi: 10.3892/or.2014.3393. Epub 2014 Aug 7.Oncol Rep. 2014.PMID: 25109834 * [ Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway. ](https://pubmed.ncbi.nlm.nih.gov/29328471/) Xu S, Zhou W, Ge J, Zhang Z.Xu S, et al.Mol Med Rep. 2018 Mar;17(3):4702-4712. doi: 10.3892/mmr.2018.8415. Epub 2018 Jan 9.Mol Med Rep. 2018.PMID: 29328471 * [ EP4 as a Therapeutic Target for Aggressive Human Breast Cancer. ](https://pubmed.ncbi.nlm.nih.gov/29596308/) Majumder M, Nandi P, Omar A, Ugwuagbo KC, Lala PK.Majumder M, et al.Int J Mol Sci. 2018 Mar 29;19(4):1019. doi: 10.3390/ijms19041019.Int J Mol Sci. 2018.PMID: 29596308Free PMC article.Review. * [ EP4 receptor as a novel promising therapeutic target in colon cancer. ](https://pubmed.ncbi.nlm.nih.gov/33190014/) Karpisheh V, Joshi N, Zekiy AO, Beyzai B, Hojjat-Farsangi M, Namdar A, Edalati M, Jadidi-Niaragh F.Karpisheh V, et al.Pathol Res Pract. 2020 Dec;216(12):153247. doi: 10.1016/j.prp.2020.153247. Epub 2020 Oct 19.Pathol Res Pract. 2020.PMID: 33190014Review. [ See all similar articles ](https://pubmed.ncbi.nlm.nih.gov/?linkname=pubmed_pubmed&from_uid=42551717) ## MeSH terms * CD55 Antigens* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22CD55+Antigens%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=CD55+Antigens) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * CD55 Antigens* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22CD55+Antigens%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=CD55+Antigens) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * Cell Line, Tumor Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell+Line%2C+Tumor%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell+Line%2C+Tumor) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * Colorectal Neoplasms* / genetics Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Colorectal+Neoplasms%2Fgenetics%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Colorectal+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * Colorectal Neoplasms* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Colorectal+Neoplasms%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Colorectal+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * Colorectal Neoplasms* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Colorectal+Neoplasms%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Colorectal+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * Dinoprostone / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Dinoprostone%2Fmetabolism%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Dinoprostone) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42551717/) * Dinoprostone / pharmacology Actions * [ Sea
## Related Clinical Research

- [Persistent Poverty, Race, and Rurality: Disparities in Cancer Mortality in Alabama](https://medichelpline.com/clinical-feed/pubmed-42812073.md) (DOI: 10.1002/cam4.72333)
- [Cancer type–specific chromatin regulator mutations linked to better survival after immune checkpoi](https://medichelpline.com/clinical-feed/medrxiv-17-cancer-type-specific-profiling-of-chromatin-regulator-mutations-identifies.md)
- [Healthy lifestyle and pan-cancer risk: UK Biobank prospective analysis](https://medichelpline.com/clinical-feed/british-journal-of-cancer-2-healthy-lifestyle-and-cancer-risk-a-pan-cancer-analysis-in-the-uk-biobank.md)
- [VEGFR2-targeted NIR-II fluorescent probe ICG-VTP for precise ovarian cancer imaging and surgical n](https://medichelpline.com/clinical-feed/pubmed-42184579.md) (DOI: 10.1016/j.bioorg.2026.110017)
- [Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)](https://medichelpline.com/clinical-feed/clinicaltrials-nct05489211.md) (DOI: NCT05489211)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.